OTC Pharmaceuticals in Japan

Datamonitor's OTC Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in Japan’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in Japan

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

[Fade out the market survey infos]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Substitutes 18
Rivalry 19
LEADING COMPANIES 20
Johnson & Johnson 20
Kracie Holdings, Ltd 25
Novartis AG 27
MARKET DISTRIBUTION 31
MARKET FORECASTS 32
Market value forecast 32
MACROECONOMIC INDICATORS 33
APPENDIX 35
Methodology 35
Industry associations 36
Related Datamonitor research 36
Disclaimer 38
ABOUT DATAMONITOR 39
Premium Reports 39
Summary Reports 39
Datamonitor consulting 39

LIST OF TABLES
Table 1: Japan OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Japan OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Japan OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Japan OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Johnson & Johnson: key facts 20
Table 6: Johnson & Johnson: key financials ($) 22
Table 7: Johnson & Johnson: key financial ratios 23
Table 8: Kracie Holdings, Ltd: key facts 25
Table 9: Novartis AG: key facts 27
Table 10: Novartis AG: key financials ($) 29
Table 11: Novartis AG: key financial ratios 29
Table 12: Japan OTC pharmaceuticals market distribution: % share, by value, 2009 31
Table 13: Japan OTC pharmaceuticals market value forecast: $ million, 2009–14 32
Table 14: Japan size of population (million), 2005–09 33
Table 15: Japan gdp (constant 2000 prices, $ billion), 2005–09 33
Table 16: Japan gdp (current prices, $ billion), 2005–09 33
Table 17: Japan inflation, 2005–09 34
Table 18: Japan consumer price index (absolute), 2005–09 34
Table 19: Japan exchange rate, 2005–09 34

LIST OF FIGURES
Figure 1: Japan OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Japan OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Japan OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Japan OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Japan, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Japan, 2009 15
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Japan, 2009 16
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Japan, 2009 17
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Japan, 2009 18
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Japan, 2009 19
Figure 11: Johnson & Johnson: revenues & profitability 23
Figure 12: Johnson & Johnson: assets & liabilities 24
Figure 13: Novartis AG: revenues & profitability 30
Figure 14: Novartis AG: assets & liabilities 30
Figure 15: Japan OTC pharmaceuticals market distribution: % share, by value, 2009 31
Figure 16: Japan OTC pharmaceuticals market value forecast: $ million, 2009–14 32


[Fade out table of contents]